Sifang Optoelectronics strategically invests in Changhe Biotechnology.

On January 16th, the strategic investment signing ceremony between Si Fang Optoelectronics and Suzhou Changhe Biotechnology Co., Ltd. was held in Shanghai. Si Fang Optoelectronics used its own funds to acquire 57.14% of the shares of Changhe Biotechnology through a combination of transfer of investment funds and additional capital injection. Through this strategic integration with Changhe Biotechnology, the two parties will deeply integrate in product technology development, operational production, and sales channels, expanding Si Fang Optoelectronics' sensor industry into the more high-end field of biosecurity detection instruments. At the same time, Si Fang Optoelectronics will leverage its core advantages in key components accumulated in the field of sensors to develop low-cost biosecurity sensors for mass applications in scenarios such as household appliances, automotive, and buildings.